Trademark: TIGEN 2180038
Word
TIGEN
Device Descrption:
CIRCLE DOTS LTR I; ANGLED STRIPES EXTEND FORM LTRS
ID
2180038
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
04 February 2021
Registration Date
04 February 2021
Renewal Date
04 February 2031

Owner(s)
Service

Goods and Services:
Class 42:
Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and/or the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, food supplement development; design and development of computer hardware and software, design and development of computer hardware and software intended for medical and scientific research and development of new products, research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and/or treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; computer software updating, maintenance and rental; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and/or the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) to be used in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and/or the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases.